MYLK/MLCK inhibitors (Origenis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameMYLK/MLCK inhibitors (Origenis)
Drug Alias Namemyosin light chain kinase inhibitors (Origenis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMyosin light chain kinase, smooth muscle inhibitors
TargetsMyosin light chain kinase, smooth muscle
Therapy Area/IndicationsCommunicable Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesOrigenis GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesOrigenis GmbH
Active IndicationsN/A
Inactive IndicationsCommunicable Diseases

Other Information

ATC CodeN/A
Related LinksN/A